# Galantos Pharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/galantos-pharma

- Industry: Biotechnology
- Headquarters: Mainz, Germany
- Website: www.galantos.com
- Total disclosed funding: $10M
- Latest round: Series C (Mar 16, 2010)
- Investors on record: 4

## About

Galantos Pharma is a biopharmaceutical company focused on the research and development of novel drugs for the treatment of neurodegenerative diseases, in particular Alzheimer‘s Disease (AD).

## Funding rounds

- Series C, Mar 16, 2010, $6M — KfW Banking Group, High-Tech Gruenderfonds, Investitions- und Strukturbank Rheinland-Pfalz, VRP Rheinland
- Series B, Jul 31, 2007, $3.8M — KfW Banking Group, High-Tech Gruenderfonds, Investitions- und Strukturbank Rheinland-Pfalz
- Series A, Mar 7, 2006, $0.7M — High-Tech Gruenderfonds

## Investors

- High-Tech Gruenderfonds (https://capitalatlas.ai/funds/high-tech-gruenderfonds) — Series A, Series B, Series C
- KfW Banking Group — Series B, Series C
- Investitions- und Strukturbank Rheinland-Pfalz (https://capitalatlas.ai/funds/investitions-und-strukturbank-rheinland-pfalz) — Series B, Series C
- VRP Rheinland — Series C
